InvestorsHub Logo
Followers 3167
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: Thedrugguru post# 9685

Thursday, 01/22/2015 2:41:38 PM

Thursday, January 22, 2015 2:41:38 PM

Post# of 38634
This board was beyond morbid for months prior to FocalinXR approval.

Only a handful here back then were taking advantage of the approx. 1.80 share price range back then.

But when FocalinXR approval hit the wires this stock shot up to a pre-market high of 6.95 and closed at 6.46 within 3 or 4 days of that news on colossal dollar volume of over a quarter BILLION dollars traded!

So IPCI definitely has a history of being completely overlooked by wall street unless and until big news hits...and when big news hits all the big boys come to play!

We have way way more valuation driving catalysts in our current pipeline than at any juncture in the past...Penna coming onboard 2 months ago is going to be very instrumental on the growth driving developments that take place over these next 2 "key" years!

Opioid's abuse is a HUGE market factor right now...and Wall Street has no clue whatsoever that IPCI's proprietary delivery platforms are not only all encompassing but are far and away the best-in-class!

Sure we need to wait for ALL the proof of those claims on the next stages of Rexista development! But if there was ever 1 drug in IPCI's pipeline that enticed Penna to jump ship from TEVA and join IPCI at this juncture it was Rexista IMO due to the landscape changing nature of IPCI's proprietary delivering platforms Rexista will cover!

Whatever IPCI's prep'n to prove with Rexista can then be applied to the ENTIRE GLOBAL opioid market! Just thinking about what that can mean over the next decade is mind-boggling and worth the wait for me glta

Love the trend not the stock - If you fail to plan your trades you plan to fail

My posts are just my own opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News